Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To demonstrate that the effectiveness of brexpiprazole (2-4 mg/day) on quality of life is
non-inferior to that of risperidone (4-6 mg/day) in adult patients with schizophrenia.